12 Aug What are the major challenges to the growth of peptides as a therapeutic class?
1.) Using the three referenced files, provide your comments as to why the pharmaceutical industry continues to be perceived as unfavorable by the consumer. ( Please use 2005 Public document for this reference) 1 paragraph for 15-20 sentences
2. From your perspective, what steps does the pharmaceutical industry need to take in order to regain the trust and confidence of the consumer? -no longer the 1 page.****** This is needed in the next 12 hours****** High priority
3. Using the referenced file, assume that you too are slow to embrace the use of genetic testing for either disease identification or therapy customization. What needs to happen to change your opinion? (Consumers Slow to Embrace the Age of Genomics (DOC) – no longer than 1 page
4.If you were able to get a copy of the referenced report, what is the one question you would hope that it answers for you? Why do you ask? Global Clinical Genomics Market Report 2021.pdf (10-15 sentences)
5. As described by Fosgerau and Hoffman, there has been tremendous progress in the development of peptide therapeutics including orally bioavailable peptides, multifunctional peptides and peptide-small molecule conjugates. What are the major challenges to the growth of peptides as a therapeutic class? 10-15 sentences 13B-Rote-Peptide Therapeutics.pdf
6. What measures would you recommend to more fully capitalize on the potential of academic drug discovery? 14B-McGonigle – Academic Drug Discovery.pdf.
